Skip to content

Translabial Tridimensional Ultrasound Imaging of Uterine Cervical Dilatation in First Stage of Labor

Intrapartum Translabial Tridimensional Ultrasound Imaging of Uterine Cervical Dilatation in First Stage of Labor - A double Blind Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12610000990022
Enrollment
100
Registered
2010-11-16
Start date
2010-02-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Sudy objective- To assess the use of non invasive intrapartum translabial 3D-US in the diagnosis of latent to active phase transition defined as an increase in cervical dilatation from 3cm to 5cm, and to compare it to digital vaginal examination. Study methods- An observational prospective double blind clinical study. Hourly consecutive translabial 3D-US volumes are obtained in singleton term patients admitted to delivery room. Sonographers are blind to patient’s digital vaginal examination partogram. Patients and delivery room personnel are blind to sonographic results. Obtained volumes will be processed offline. Ultrasound maximal cervical diameter and vaginal digital examination will be compared.

Interventions

Intrapartum translabial 3D ultrasonographic imaging of uterine cervix using a Voluson 750 ultrasound system, GE Healthcare, Kretztechnik, Zipf, Austria, with a RAB2-5-RS 2- to 5-MHz convex 4-dimensional probe. A wrapped ultrasound transducer is placed over patient's perineum, A volume acquisition (lasting around 30seconds) is repeated hourly until cervical dilatation of 5cm is reached

Sponsors

Ariel L ZImerman
Lead SponsorIndividual

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Included were all term (equal or greater than 37 weeks) low risk singleton parturients admitted to our delivery room with the diagnosis of labor as defined elsewhere who agreed to participate in the study and signed a detailed informed consent

Exclusion criteria

Excluded were preterm patients, multiple pregnancies and non vertex presentations. Participation was stopped in case of patient or delivery room team request; and in case of an obstetrical risk factor such as nonreassuring fetal heart rate tracing, vaginal bleeding, pre-eclampsia or the need for emergency intervention.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026